# Safety and efficacy of P2X3 receptor antagonist for the treatment of refractory or unexplained chronic cough: A systematic review and meta-analysis of 11 randomized controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-p2x3-receptor-antagonist-for-the-treatment-of-refractory/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alaa Ramadan,Mohamed El‐Samahy,Amr Elrosasy,Mohammed Al‐Tawil,Ahmed Abdelaziz,Mostafa A Soliman,Mohamed Abouzid |
| Citations | 9 |
| DOI | 10.1016/j.pupt.2023.102252 |
| Fields | Health Professions,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4386529816 |
| PMID | 37678663 |
| Type | review |
| Year | 2023 |

## Paper authors

- [Amr Elrosasy](https://scholariq.org/researchers/amr-elrosasy/)

## Paper journal

- [Pulmonary Pharmacology & Therapeutics](https://scholariq.org/journals/pulmonary-pharmacology-and-therapeutics/)

## Paper primary topic

- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)

## Paper topics

- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Pediatric health and respiratory diseases](https://scholariq.org/topics/pediatric-health-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.